microdose semaglutide GLP-1 microdosing is popular, but there's little evidence it works Microdosing Semaglutide: Does It Work

Other Serious Risks Intestinal Blockage (Ileus) Added to Label: September 2023 Symptoms: Severe abdominal pain, inability to pass gas or stool, severe bloating, vomiting Risk: Can require emergency surgery to correct Pancreatitis Added to Label: January 2025 Symptoms: Severe upper abdominal pain, nausea, vomiting, fever Risk: Necrotizing pancreatitis can be life-threatening Kidney Injuries Added to Label: January 2025 Cause: Often related to severe dehydration from persistent vomiting Risk: Acute kidney injury requiring hospitalization Gallbladder Disease Research: 2023 JAMA study linked higher doses to increased risk Symptoms: Severe pain in upper right abdomen, nausea, jaundice Outcome: Often requires gallbladder removal surgery The Side Effects Everyone Gets (But Still Takes the Drug) Nausea: ~50% of users (RAND survey) Diarrhea: ~33% of users Stopped Due to Side Effects: 13% of users Stopped Due to Cost: 14% of users According to the RAND American Life Panel survey of 8,793 Americans, about half of GLP-1 users experienced nausea and roughly one-third experienced diarrhea

Heres a closer look at the most common female-specific side effects: Genital yeast infections

By enhancing internal drainage, this innovation aims to accelerate patient recovery times, enable a faster return to daily life, and reduce the need for additional, invasive treatment procedures

Non-glycolytic pathways of metabolism of glucose

Vitamin C is renowned for reducing the duration and severity of cold symptoms